Data and Digitization Will Drive the Future of Healthcare
The last year brought a variety of changes to the healthcare and life sciences that are accelerating the pace of innovation. Health Catalyst host Daniel Litwin was joined by Sadiqa Mahmood, Senior Vice President and General Manager of the Life Sciences business at Health Catalyst, to delve into these changes, exciting innovations and the emerging…
This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.
Free workspace
Turn your Healthcare expertise into content.
Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.
The last year brought a variety of changes to the healthcare and life sciences that are accelerating the pace of innovation.
Health Catalyst host Daniel Litwin was joined by Sadiqa Mahmood, Senior Vice President and General Manager of the Life Sciences business at Health Catalyst, to delve into these changes, exciting innovations and the emerging trends in life sciences.
“Navigating this ongoing COVID-19 pandemic has been an all-encompassing, once-in-a-lifetime challenge and experience for the life science sector,” Mahmood said.
The accelerated pace of COVID vaccine development revealed potential efficiencies in the industry, and Mahmood has identified some of the major trends. Companies have learned the value of building partnerships in the interest of population health, and one of the biggest changes is the overall increase in digitization of patient care and drug development.
Data that was previously siloed can be mined for innovations and actionable insights. Digitization and data management have also brought efficiencies in the supply chain for medicine and medical equipment while allowing for decentralized clinical trials. Remote patient monitoring and telehealth have expanded the reach of healthcare practices.
Overall, these innovations have made healthcare less site-centric and more patient-centric.
Mahmood believes these challenges have brought opportunities for getting drugs to patients sooner, reaching as many patients as possible and doing all of it at a lower cost.
The difficulties of dealing with COVID-19 have revealed potential efficiencies and will continue to bring positive benefits to patients and providers.
Follow us on social media for the latest updates in B2B!
Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale
Your experts belong here
Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.
Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.
